STAAR Surgical (STAA)
(Real Time Quote from BATS)
$40.81 USD
-0.71 (-1.71%)
Updated Jul 30, 2024 12:38 PM ET
3-Hold of 5 3
D Value B Growth B Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
STAA 40.81 -0.71(-1.71%)
Will STAA be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for STAA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for STAA
Staar Surgical (STAA) Soars 7.5%: Is Further Upside Left in the Stock?
Don't Overlook Staar Surgical (STAA) International Revenue Trends While Assessing the Stock
STAA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Staar Surgical (STAA) Reports Q1 Earnings: What Key Metrics Have to Say
Wall Street's Insights Into Key Metrics Ahead of Staar Surgical (STAA) Q1 Earnings
Dentsply International (XRAY) Meets Q1 Earnings Estimates
Other News for STAA
STAAR Surgical to Participate in Canaccord Genuity 44th Annual Growth Conference
Stifel Nicolaus Sticks to Their Buy Rating for Staar Surgical (STAA)
Stanley Electric Rewards Directors with Stock Plan
10 Health Care Stocks Whale Activity In Today's Session
Staar Surgical Co's Meteoric Rise: Unpacking the 21% Surge in Just 3 Months